Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study

NCT02308124 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

87

Enrollment

OTHER

Sponsor class

Conditions

Orthostatic; Hypotension, Neurogenic

Interventions

DRUG: Midodrine
DRUG: Pyridostigmine Bromide
DRUG: Midodrine + pyridostigmine

Sponsor

Seoul National University Hospital